Clinical and Economical Evidence

Intermittent Pneumatic Compression (IPC) has proved to be a very safe and effective method for promoting patient wellness, by reducing the immediate and long-term costs associated with Deep Vein Thrombosis (DVT).

More about VTE Prevention

The Arjo Clinical Evidence Document presents a comprehensive summary of the key clinical and economic evidence.

Topics covered include:

  • The global impact of Venous Thromboembolism (VTE)
  • The pathophysiology of VTE
  • The risks, according to each clinical specialty
  • Intermittent Pneumatic Compression (IPC) – mode of action
  • Summary of consensus guidelines
  • A comprehensive listing of key laboratory, clinical, and safety studies related to Flowtron® IPC devices
  • Full reference listing


Please click here to download the Arjo Clinical Evidence Brochure.

Clinical Evidence Brochure